You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Combination%20Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphedema Arm Trial (BioBridge)

Not yet recruiting
  • Lymphedema Arm
  • BioBridge
  • (no location specified)
Apr 20, 2023

TNFi as Monotherapy or Combination Therapy With MTX and Compare

Completed
  • Rheumatoid Arthritis
  • patterns of use of combination therapy and monotherapy
  • New York, New York
    Pfizer
Oct 7, 2022

Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)

Recruiting
  • Androgenetic Alopecia
  • Minoxidil 5% Topical Solution
  • microneedling
  • Jakarta, DKI Jakarta, Indonesia
    Cipto Mangungkusumo Hospital
Aug 3, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Aug 31, 2023

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • combination therapy with no MEKi
  • +3 more
  • (no location specified)
Nov 29, 2022

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational

Not yet recruiting
  • Metastatic Cancers
  • Fatigue
  • Psychoeducational Intervention
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Centerr
Oct 10, 2023

Osteoradionecrosis, Osteoradionecrosis of Jaw, Osteoradionecrosis of the Mandible Trial (modified PENTOCLO (mPENTOCLO), sham

Not yet recruiting
  • Osteoradionecrosis
  • +2 more
  • modified PENTOCLO (mPENTOCLO)
  • sham mPENTOCLO
  • (no location specified)
Sep 19, 2023

Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)

Recruiting
  • Essential Hypertension
  • D064 and D702, QD
  • +2 more
  • Seoul, Seongdong-gu, Korea, Republic of
    Hanyang University Seoul Hospital
Nov 7, 2023

Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Trial in Duarte (procedure, drug, other)

Not yet recruiting
  • Advanced Prostate Carcinoma
  • +4 more
  • Bright White Light Therapy
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 8, 2023

Migraine Trial in Dhaka (Topiramate 25Mg Tab, Amitriptyline 25 Mg Oral Tablet, topiramate 25mg plus amitriptyline 25mg)

Enrolling by invitation
  • Migraine
  • Topiramate 25Mg Tab
  • +2 more
  • Dhaka, Bangladesh
    Dhaka Medical College
Feb 26, 2023

Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)

Recruiting
  • Non-healing Wound
  • Non-Healing Ulcer of Skin
  • Omeza Products Used in Combination
  • Santa Fe, New Mexico
    Christus St. Vincent
Jun 19, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • JS015
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 17, 2023

Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • (no location specified)
Jan 27, 2023

Primary Condition: Advanced Tumors Trial in Guangzhou (JS009 as a monotherapy and JS009 as a Triple Combination Therapy in

Not yet recruiting
  • Primary Condition: Advanced Tumors
  • JS009 as a monotherapy and JS009 as a Triple Combination Therapy in Combination with Toripalimab and JS006
  • Blacktown, New South Wales, Australia
  • +3 more
Feb 1, 2023

Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

Not yet recruiting
  • Chronic Hepatitis Delta
  • Peginterferon Lambda
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 25, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Malaria Trial in Kasese (Artemether/lumefantrine, Ivermectin)

Recruiting
  • Malaria
  • Kasese, Uganda
    ST. Paul's Health Center
Oct 31, 2022

Cutaneous Warts Trial in Antwerp (AV2-SA2, SA)

Completed
  • Cutaneous Warts
  • Antwerp, Belgium
    University of Antwerp
May 7, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

Recruiting
  • Sarcoma,Soft Tissue
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023